Meeder Asset Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-4
Closed 877
2022
Q3
$0 Sell
4
-3
-43% -$137 ﹤0.01% 2143
2022
Q2
$0 Hold
7
﹤0.01% 2172
2022
Q1
$0 Buy
+7
New +$454 ﹤0.01% 2323
2021
Q4
Sell
-8
Closed -$1K 1235
2021
Q3
$1K Hold
8
﹤0.01% 2277
2021
Q2
$1K Hold
8
﹤0.01% 2304
2021
Q1
$1K Hold
8
﹤0.01% 2172
2020
Q4
$0 Buy
8
+1
+14% +$43 ﹤0.01% 1877
2020
Q3
$0 Sell
7
-357
-98% -$15.1K ﹤0.01% 2163
2020
Q2
$15K Sell
364
-700
-66% -$30.5K ﹤0.01% 1201
2020
Q1
$37K Buy
1,064
+724
+213% +$26K ﹤0.01% 1021
2019
Q4
$11K Buy
+340
New +$9.68K ﹤0.01% 1528

Other funds holding ATRC

Meeder Asset Management's ATRC Position: Q4 2022 in Review

Meeder Asset Management sold out of AtriCure (ATRC) in Q4 2022, closing a stake of 4 shares.

Meeder Asset Management first reported a position in ATRC in Q4 2019 and held it in 11 quarters. The position peaked at $37K in Q1 2020. 211 funds tracked by Wall St. Rank hold ATRC as of Q4 2022.

  • Meeder Asset Management reported no remaining AtriCure position as of Q4 2022 after selling out during the quarter.
  • Meeder Asset Management sold 4 AtriCure shares in Q4 2022.
  • Meeder Asset Management first reported a position in AtriCure in Q4 2019 and held it in 11 quarters.
  • Meeder Asset Management's AtriCure position peaked at $37K in Q1 2020.
  • 211 funds tracked by Wall St. Rank held AtriCure as of Q4 2022.

Based on Meeder Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.